Prolonged survival in a patient with pbrm1 mutated metastatic cholangiocarcinoma receiving tazemetostat.

However, this finding did not reach statistical significance, and further studies are required to confirm the association.

also in 111,027 other papers

Our analysis showed a trend towards increased sensitivity to GSK343 among cell lines with PBRM1 mutations (Fig. 2E ).

also in 53,322 other papers